SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs
November 03, 2021 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapies for chronic autoimmune diseases, today announced the...
SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows
March 03, 2021 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that the...
SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
February 01, 2021 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced the enrollment...
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform
January 27, 2021 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with...
SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform
October 06, 2020 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for...
The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis
July 29, 2020 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that data from a first-in-human pilot trial that evaluated its proprietary Vagus Nerve Stimulation (VNS)...
SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients
May 06, 2020 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that it has...
SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019
November 14, 2019 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that Murthy...
SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019
October 29, 2019 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results...
SetPoint Medical Appoints Anna Gawlicka as VP of Clinical Affairs
September 10, 2019 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage company developing therapy for chronic autoimmune diseases, today announced the appointment of Anna Gawlicka,...